Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Alectinib [USAN:INN]
RN: 1256580-46-7
UNII: LIJ4CT1Z3Y
InChIKey: KDGFLJKFZUIJMX-UHFFFAOYSA-N

Note

  • An anaplastic lymphoma kinase (Alk) inhibitor.

    NCI: An orally available inhibitor of the receptor tyrosine kinase anaplastic lymphoma kinase (ALK) with antineoplastic activity. Upon administration, alectinib binds to and inhibits ALK kinase, ALK fusion proteins as well as the gatekeeper mutation ALKL1196M known as one of the mechanisms of acquired resistance to small-molecule kinase inhibitors. The inhibition leads to disruption of ALK-mediated signaling and eventually inhibits tumor cell growth in ALK-overexpressing tumor cells. ALK belongs to the insulin receptor superfamily and plays an important role in nervous system development. ALK dysregulation and gene rearrangements are associated with a series of tumors.(NCI Thesaurus)

Molecular Formula

  • C30-H34-N4-O2

Molecular Weight

  • 482.6246
 

Classification Code

  • Antineoplastic Agents
* denotes mobile formatted website

Links to Resources


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • Alectinib [USAN:INN]

Synonyms

  • AF 802
  • AF-802
  • Alecensa
  • Alectinib
  • CH 5424802
  • CH5424802
  • UNII-LIJ4CT1Z3Y

Registry Numbers

CAS Registry Number

  • 1256580-46-7

FDA UNII

  • LIJ4CT1Z3Y

Other Registry Number

  • 1416163-60-4

System Generated Number

  • 1256580467

Structure Descriptors

InChI

1S/C30H34N4O2/c1-4-20-16-23-24(17-26(20)34-9-7-21(8-10-34)33-11-13-36-14-12-33)30(2,3)29-27(28(23)35)22-6-5-19(18-31)15-25(22)32-29/h5-6,15-17,21,32H,4,7-14H2,1-3H3

InChIKey

KDGFLJKFZUIJMX-UHFFFAOYSA-N

Smiles

CCc1cc2c(cc1N3CCC(CC3)N4CCOCC4)C(c5c(c6ccc(cc6[nH]5)C#N)C2=O)(C)C